| Adaptability of non-genetic diversity in bacterial chemotaxis NW Frankel, W Pontius, YS Dufour, J Long, L Hernandez-Nunez, ... Elife 3, e03526, 2014 | 102 | 2014 |
| Synthetic cytokine circuits that drive T cells into immune-excluded tumors GM Allen, NW Frankel, NR Reddy, HK Bhargava, MA Yoshida, SR Stark, ... Science 378 (6625), eaba1624, 2022 | 80 | 2022 |
| Behavioral variability and phenotypic diversity in bacterial chemotaxis AJ Waite, NW Frankel, T Emonet Annual review of biophysics 47 (1), 595-616, 2018 | 76 | 2018 |
| Direct correlation between motile behavior and protein abundance in single cells YS Dufour, S Gillet, NW Frankel, DB Weibel, T Emonet PLoS computational biology 12 (9), e1005041, 2016 | 67 | 2016 |
| Engineering cell–cell communication networks: programming multicellular behaviors S Toda, NW Frankel, WA Lim Current opinion in chemical biology 52, 31-38, 2019 | 65 | 2019 |
| Non‐genetic diversity modulates population performance AJ Waite, NW Frankel, YS Dufour, JF Johnston, J Long, T Emonet Molecular systems biology 12 (12), 895, 2016 | 63 | 2016 |
| Design of DNA-conjugated polypeptide-based capture probes for the anchoring of proteins to DNA matrices RM Schweller, PE Constantinou, NW Frankel, P Narayan, MR Diehl Bioconjugate chemistry 19 (12), 2304-2307, 2008 | 27 | 2008 |
| FLT3 OR CD33 NOT EMCN logic gated CAR-NK cell therapy (SENTI-202) for precise targeting of AML BS Garrison, H Deng, G Yucel, NW Frankel, M Guzman-Ayala, R Gordley, ... Blood 138, 2799, 2021 | 10 | 2021 |
| Abstract LB028: Development of logic-gated CAR-NK cells to reduce target-mediated healthy tissue toxicities A Gonzalez, A Roguev, NW Frankel, BS Garrison, D Lee, M Gainer, ... Cancer Research 81 (13_Supplement), LB028-LB028, 2021 | 10 | 2021 |
| Junjiajia Long, Luis Hernandez-Nunez, and Thierry Emonet. 2014. Adaptability of non-genetic diversity in bacterial chemotaxis NW Frankel, W Pontius, YS Dufour Elife 3, e03526, 2014 | 7 | 2014 |
| Precise targeting of AML with first-in-class OR/NOT logic-gated gene circuits in CAR-NK Cells BS Garrison, H Deng, G Yucel, NW Frankel, MA Guzman, R Gordley, ... MOLECULAR THERAPY 29 (4), 38-39, 2021 | 4 | 2021 |
| Senti-202, a selective, off-the-shelf, preclinical CAR-NK cell therapy with CD33 and/or FLT3 activating CAR, healthy cell protection from endomucin (EMCN) inhibitory CAR and … B Garrison, H Deng, G Yucel, NW Frankel, R Gordley, M Hung, D Lee, ... Blood 140 (Supplement 1), 4531-4532, 2022 | 2 | 2022 |
| Precision off-the-shelf natural killer cell therapies for oncology with logic-gated gene circuits NW Frankel, H Deng, G Yucel, M Gainer, N Leemans, A Lam, Y Li, ... Cell Reports 43 (5), 2024 | 1 | 2024 |
| 221 SENTI-401, an allogeneic logic-gated and multi-armed CAR-NK cell therapy for the treatment of CEA-expressing solid tumors with enhanced selectivity and efficacy AG Junca, N Frankel, M Morvan, A Roguev, M Hung, R Gordley, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| Logic gated FLT3 or CD33 not EMCN CAR-NK cell therapy (SENTI-202) for precise targeting of AML B Garrison, H Deng, G Yucel, N Frankel, R Gordley, M Hung, D Lee, ... Molecular Therapy 30 (4), 398-399, 2022 | 1 | 2022 |
| Building a Stable Relationship: Ensuring Homeostasis among Cell Types within a Tissue NW Frankel, WA Lim Cell 172 (4), 638-640, 2018 | 1 | 2018 |
| Non‐genetic diversity modulates population performance AJ Waite, NW Frankel, YS Dufour, JF Johnston, J Long, T Emonet Molecular Systems Biology 14 (1), e8149, 2018 | 1 | 2018 |
| Chimeric receptors and methods of use thereof A Gonzalez-Junca, N Frankel, AB Roguev US Patent App. 18/504,037, 2024 | | 2024 |
| Chimeric receptors and methods of use thereof BS Garrison, A Gonzalez-Junca, G Lee, AB Roguev, FD Liu, N Frankel US Patent App. 18/201,596, 2024 | | 2024 |
| Tunable Universal OR-gated CAR T cells for AML MY Siddiqui, J Chen, M Loffredo, S Lee, H Deng, Y Li, N Leemans, T Lu, ... bioRxiv, 2024.04. 13.589307, 2024 | | 2024 |
